StockInvest_us Posted - 2 days ago

Signal alert: $LGND - Oversold Trend Short (Undervalued) https://stockinvest.us/l/qWXH9IF0I1

Stock_Titan Posted - 2 days ago

$LGND Ligand to Report First Quarter 2024 Financial Results on May 7, 2024 https://www.stocktitan.net/news/LGND/ligand-to-report-first-quarter-2024-financial-results-on-may-7-yjicfzsg4j3x.html

novumcarpediem Posted - 1 week ago

@LeLionEtLeRat It's crazy. How can these companies be so naive and trust disclosing their IP to Wuxi ?! These companies $LGND and $KYTX are done. I wouldn't even be surprised if these Cos lose their FTO from patent and Tech theft.

LeLionEtLeRat Posted - 1 week ago

@novumcarpediem thanks for the note! $LGND is not mention but they're exposed too. https://investor.ligand.com/news-and-events/press-releases/news-details/2018/Ligand-Receives-47-Million-from-WuXi-Biologics-for-Expansion-of-Worldwide-OmniAb-Platform-License-Agreement-06-27-2018/default.aspx

vjtweet Posted - 1 week ago

$LGND opened long

Okenrav Posted - 1 week ago

@LeLionEtLeRat Thanks! The Chinese are losing this one. $VKTX got all the drugs they're developing right now from $LGND . So there is a paper trail of the development of these molecules. I do not see this as something that would impede a BO.

Unicorn2020 Posted - 2 weeks ago

$TSVT Back in @ $5.00 this morning. we will trade in tandem with $LGND

Stock_Titan Posted - 2 weeks ago

$LGND Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference https://www.stocktitan.net/news/LGND/ligand-pharmaceuticals-announces-new-topiramate-injection-data-e88o8stfth4g.html

StockInvest_us Posted - 3 weeks ago

Signal alert: $LGND - PivotPoint bottom https://stockinvest.us/l/3X4ldloAco

Stock_Titan Posted - 3 weeks ago

$LGND Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™ https://www.stocktitan.net/news/LGND/ligand-pharmaceuticals-announces-launch-of-pelthos-therapeutics-to-zmpyde9ki690.html

hooks2 Posted - 03/28/24

$LGND

hooks2 Posted - 03/28/24

$LGND

hooks2 Posted - 03/28/24

$LGND

hooks2 Posted - 03/28/24

$LGND

hooks2 Posted - 03/28/24

$LGND

StockInvest_us Posted - 03/28/24

Signal alert: $LGND - Possible Runner https://stockinvest.us/l/JggV0PmoC4

LeLionEtLeRat Posted - 03/27/24

$VKTX Interesting... $lgnd has a strong track record in helping biotechs to get FDA approvals... Article from SA below. Ligand Pharmaceuticals ($LGND) rose 4.2% amid an investor pitch. The pharmaceutical firm was pitched by Sandy Villere of Villere & Co. in an interview on CNBC earlier on Wednesday. "Ligand is basically a chicken way to play the biotech industry," Villere said on the business network. "This gives you many many shots on goal for success." He highlighted that a $1.8 million investment that Ligand (LGND) made in 2010 turned out to be Viking Therapeutics ($VKTX) and their stake is now valued at $140 million. Ligand has a market cap of $1.2 billion, while Viking is valued at $8.8 billion. "I'm sorta making an investment in the 35 veteran scientists that work at Ligand to make these incredible investments and deliver shareholder returns over the long run," Villere explained. https://seekingalpha.com/news/4084624-ligand-pharmaceuticals-gains-amid-bullish-investor-pitch?mailingid=34840737&messageid=2900&serial=34840737.56&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha&utm_term=34840737.56

BelieveInYourSelf Posted - 03/27/24

$LGND is VKTX worth about $7/sh (about $140 mil) in their portfolio?

sxsess Posted - 03/27/24

$LGND this stock has huge upside with a small float!

ViractaTrader77 Posted - 1 month ago

$LGND check out this leukemia co 40% cr’s in AML $12 mil market cap molecule from MD Anderson $24 mil cash https://player.vimeo.com/video/915686201?h=fb9d821f85 $BLUE $IBRX

Aigner_Andreas Posted - 1 month ago

TD BUY $LGND at 62.65, Supp 62.65 Resis 89.20 R42 HiLo 30% T1Y 149 buy 2.0 PE 26.1 DIV N/A #Ligand Pha #stocks #trading #finance #market

insiderbuyingselling Posted - 1 month ago

$LGND new insider selling: 1893 shares. http://insiderbuyingselling.com/?t=LGND

DoubleDownDave Posted - 1 month ago

$LGND Ligand Pharmaceuticals Incorporated (LGND) just filed a Statement of changes in beneficial ownership of securities. A summary of the filing is available below: Ligand Pharmaceuticals Incorporated director just picked up 2,893 shares

canesmonkey Posted - 1 month ago

$LGND So we gave back the whole spike ... gotta love biotechnology

DailyStocksPicks Posted - 1 month ago

Today's Pick number three is $IRWD. Ironwood Pharmaceuticals develops gastrointestinal healthcare medications. IRWD appears to be considered oversold due to a combination of mixed results from its gastrointestinal drug trial and a miss in its Q4 2023 earnings expectations. Although the company announced positive outcomes from its Phase III STARS trial for apraglutide in treating short bowel syndrome with intestinal failure, the failure of its gastrointestinal drug to significantly aid a patient subgroup led to a sharp decline in its share price, erasing a 38% gain. The earnings miss further exacerbated investor concerns, with reported earnings per share falling short of expectations. $DVAX, $KURA, $LGND, $BHC For more details https://youtu.be/72VEwGgjaEw

Stock_Titan Posted - 1 month ago

$LGND Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference https://www.stocktitan.net/news/LGND/ligand-pharmaceuticals-to-present-at-barclays-26th-annual-global-ybb45w53mg8t.html

Stock_Titan Posted - 1 month ago

$LGND Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/LGND/ligand-pharmaceuticals-announces-inducement-grants-under-nasdaq-op4vknh1niwp.html

DailyStocksPicks Posted - 1 month ago

Ironwood Pharmaceuticals, Inc. ($IRWD) stock appears to be considered oversold due to a combination of mixed results from its gastrointestinal drug trial and a miss in its Q4 2023 earnings expectations. Although the company announced positive outcomes from its Phase III STARS trial for apraglutide in treating short bowel syndrome with intestinal failure (SBS-IF), the failure of its gastrointestinal drug to significantly aid a patient subgroup led to a sharp decline in its share price, erasing a 38% gain. The earnings miss further exacerbated investor concerns, with reported earnings per share (EPS) falling short of expectations​​​​​​. $DVAX, $KURA, $BHC, $LGND For more details https://youtu.be/QDW75yHzRo0

DailyStocksPicks Posted - 1 month ago

$IRWD Ironwood Pharmaceuticals develops gastrointestinal healthcare medications. The perception that Ironwood Pharmaceuticals is oversold appears to stem from a confluence of factors, including mixed results from its key gastrointestinal drug trial which led to significant share price decline, an earnings miss for Q4 2023, divergent analyst ratings ranging from sell to overweight with varying price targets, recent insider sales reported in SEC filings, and volatile stock price movements within a broad 52-week range. Additionally, social media sentiment suggests investor confusion and disagreement about the stock's valuation, considering the company's progress with its drug trials and potential market opportunities​​​​​​. $DVAX $KURA $BHC $LGND For more details https://youtu.be/5WSzPuYhAF0

Posna Posted - 02/28/24

$LGND PAR